Indeed, recently it was reported that the OPTN mutation E478G promotes inflammation and induces neuronal cell death in vitro and in mouse models, which suggests that anti-inflammatory treatment could represent a powerful tool to intervene in the disease progression in ALS patients who harbor mutations in the OPTN gene [119]. The gene discussed is OPTN; the disease is amyotrophic lateral sclerosis.